Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.15
Bid: 3.80
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.70 (18.421%)
Open: 4.15
High: 4.15
Low: 4.15
Prev. Close: 4.15
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment Update

6 Apr 2021 07:00

RNS Number : 3924U
Primorus Investments PLC
06 April 2021
 

Primorus Investments plc

 

("Primorus" or the "Company")

Investment Update

Primorus (AIM: PRIM) is pleased to provide its shareholders with the following updates on a number of its investee companies.

Engage Technology Partners ("Engage"), the end-to-end workforce management platform provider, has recently completed an equity fundraising resulting in the conversion of loan notes which investors, including the Company, subscribed for last year as part of the Government's Future Fund initiative. Following the conversion, which was completed at a discount of 20 per cent. to the equity fundraising, Primorus now holds 92,374 ordinary shares in the capital of Engage, equating to approximately 4 per cent. of its fully diluted share capital.

Engage is an end-to-end workforce management platform that connects recruitment agencies, end hirers and contractors. Its cloud-based solution creates visibility across the paid to recruit process. As well as ensuring worker compliance, companies mitigate their tax liability risk. Cost management is made easier with transparency across companies' contractor pools. For more information, see: https://www.engagetech.com/

The Company is also pleased to provide an update on Zuuse Limited ("Zuuse"), a leading global software provider operating in the construction and building operations sector. Despite 2020 being a challenging year due to the global Covid-19 pandemic, Zuuse's revenue for the 12 months ending 31 December 2020 was up by 15 per cent. versus the comparable period last year and despite falling 7 per cent. during Q2 2020. The business was also EBITDA and cashflow positive throughout the period, which has provided a strong base moving into 2021 to increase the investment in the business to drive sales and revenue growth. Zuuse enjoyed record sales in December 2020. Management is optimistic that increased levels of investment in sales, marketing and product, along with an improving level of confidence in the economy, will result in a stronger trading performance in 2021; a view supported by results to date in 2021. For more information, see: www.zuuse.com

Primorus notes the announcement by TruSpine Technologies plc ("TruSpine") on 1 April that it has completed a share subscription to raise £585,000. Whilst the Company did not participate in the subscription, it is hoped the fundraise will further advance TruSpine through its FDA application process and commercial launch of its Cervi-LOK™ device. For more information, see http://truspine.org/ 

Rupert Labrum, Executive Chairman, commented: "We are pleased to continue our support of the Engage team. Whilst we did not invest in the recent fundraising, we have been impressed with the team and the business they have built. It has been promising to see the growth the business has enjoyed, particularly through the Covid-19 pandemic.

Likewise, the resilience of the Zuuse team, coupled with their leading software solutions, has been rewarded by the business's underlying performance. As confidence in the economy grows, we fully expect Zuuse to continue to execute its ambitious growth plans."

 

For further information, please contact:

Primorus Investments plc +44 (0) 20 8154 7907

Rupert Labrum

 

Nominated Adviser and Broker

Cairn Financial Advisers LLP +44 (0) 20 7213 0880

Sandy Jamieson / James Caithie

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGZGGDVMFGMZM
Date   Source Headline
15th Apr 20247:00 amRNSInvestee Company Update – Engage Technology
25th Mar 20247:00 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSHolding(s) in Company
19th Mar 20242:45 pmRNSFurther re Dividend Declaration
11th Mar 20244:51 pmRNSDividend Declaration
8th Mar 202411:49 amRNSFurther Investment in Fresho Pty Ltd
27th Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSInvestee Company Update – Payapps Limited
2nd Feb 20243:26 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSInvestee Company Update – Payapps Limited
11th Oct 20239:59 amRNSDirector/PDMR Shareholding
28th Sep 20235:27 pmRNSDirector/PDMR Shareholding
19th Sep 20234:50 pmRNSHolding(s) in Company
15th Sep 20237:41 amRNSFurther re Investment in Interpac & Bushveld CLN
18th Aug 20233:12 pmRNSHalf-year Report
15th Aug 202312:06 pmRNSResult of AGM
2nd Aug 202310:25 amRNSAlteration Earth - Investment Update
20th Jul 20237:00 amRNSNotice of AGM
14th Jul 20234:00 pmRNSBushveld Convertible Loan Note Update
20th Jun 20237:00 amRNSConsent to Electronic Communication
16th Jun 20233:18 pmRNSFinal Results
16th Mar 20232:50 pmRNSDirector/PDMR Shareholding
19th Jan 20233:25 pmRNSHolding(s) in Company
19th Jan 20233:23 pmRNSDirector/PDMR Shareholding
8th Dec 20227:01 amRNSHolding(s) in Company
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
29th Nov 202211:05 amRNSSecond Price Monitoring Extn
29th Nov 202211:00 amRNSPrice Monitoring Extension
13th Sep 20223:50 pmRNSInvestment in Interpac Ltd
2nd Sep 20222:00 pmRNSHalf-year Report
1st Jul 20228:23 amRNSInvestment Update
30th Jun 202210:43 amRNSResult of AGM
10th Jun 20223:00 pmRNSFinal Results
6th Jun 202211:39 amRNSUpdate on Alteration Earth PLC Investment
31st May 20223:58 pmRNSNotice of AGM
4th May 202212:33 pmRNSUpdate on Alteration Earth PLC Investment
5th Apr 20227:00 amRNSUpdate on Alteration Earth PLC Investment
30th Mar 20228:12 amRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFurther re Investment in Mustang
17th Mar 20224:12 pmRNSFurther Investment in Rambler Metals & Mining PLC
16th Mar 20221:05 pmRNSCancellation of Share Options
8th Mar 202210:48 amRNSUpdate on Alteration Earth PLC Investment
28th Feb 20224:45 pmRNSFurther re Investment in Mustang
16th Feb 20227:00 amRNSGeneral Update & Clean Power Hydrogen Investment
3rd Feb 20227:00 amRNSInvestment in Rambler Metals & Mining PLC
31st Jan 202210:54 amRNSAlteration Earth Update
19th Jan 20228:01 amRNSFurther re Investment in Mustang
24th Dec 202110:11 amRNSAlteration Earth update
21st Dec 20217:00 amRNSUpdate on Mustang Energy Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.